Modulation of apomorphine-induced stereotyped behavior by cholecystokinin

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 21, Issue 4, 1997, Pages 683-695

  Tieppo, Carla A ^a   Nasello, Antonia G ^a   Felicio, Luciano F ^b  

^a Medical School of Santa Casa   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

apomorphine; brain peptide; CCK4; CCK8; dopamine; stereotypy; striatum

Indexed keywords

APOMORPHINE; CHOLECYSTOKININ A RECEPTOR; CHOLECYSTOKININ B RECEPTOR; CHOLECYSTOKININ OCTAPEPTIDE; DOPAMINE; TETRAGASTRIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR DISORDER; BLOOD BRAIN BARRIER; CONTROLLED STUDY; CORPUS STRIATUM; DOSE RESPONSE; DRUG MECHANISM; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; RAT; STEREOTYPY;

ANIMALS; APOMORPHINE; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; RATS; RATS, WISTAR; SINCALIDE; STEREOTYPED BEHAVIOR;

EID: 0030943969     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-5846(97)00041-9     Document Type: Article

References (38)

1. ALTAR, C.A. and BOYAR, W.C. (1989) Brain CCK-B receptors mediate the supression of dopamine release by cholecystokinin. Brain Res 483: 321-326.
2. BERNARDI, M.M., DE SOUZA, H., and PALERMO NETO, J. (1981) Effects of single and long-term haloperidol administration on open field behavior of rats. Psychopharmacol. 73:171-175.
3. CRAWLEY, J.N., STIVERS J.A., BLUMSTEIN L.K. and PAUL S.M. (1985) Cholecystokinin potentiates dopamine-mediated behaviors : evidence for modulation specific to a site of coexistence. J. Neurosci. 5:1972-1983.
4. CRAWLEY, J.N. (1991) Cholecystokinin-dopamine interactions. TIPS, 12:232-236.
5. CRAWLEY, J.N., FISKE, S.M., DURIEUX, C., C., DERRIEN, M. and ROQUES, B.P. (1991) Centrally administered cholecystokinin suppresses feeding through a peripheral-type receptor mechanism. J. Pharmacol. Exp. Ther. 257:1076-1080.
6. CRAWLEY, J.N. (1994) Cholecystokinin modulates dopamine-mediated behaviors. Ann. NY Acad. Sci. 713: 138-142.
7. DAVIDOWA, H., ALBRECHT, D., GABRIEL, H.-J. HEUBLEIN, S. and WETZEL, K. (1995) Cholecystokinin excites neostriatal neurons in rats via CCKA or CCKB receptors. Eur. J. Neurosci. 7: 2364-2369.
8. DING, X-Z. and MOCHETTI, I. (1992) Dopaminergic regulation of cholecystokinin mRNA content in rat striatum. Mol. Brain Res. 12:77-83.
9. DOCKRAY, G.J.R. (1976) Immunochemical evidences of cholecystokinin-like peptides in brain. Nature 264:568-570.
10. FELICIO, L.F.; MANN, P.E. and BRIDGES, R.S. (1991) Intracerebroventricular cholecistokinin infusions block beta-endorphine induced disruption of maternal behavior in lactanting rats. Pharmacol. Biochem Behav. 39: 201-204
11. FINK, H., MORGENSTERN, R. and OTT, T. (1991) CCK-8 modulates D2 receptor agonist-induced hypermotility in the nucleus accumbens. Brain Res. Bull. 26: 437-440.
12. 3H-MK-329. J. Neurosci. 10:1070-1081.
13. KARIYA, K., TANAKA, J. and NOMURA, M. (1994) Sistemic administration of CCK-8S, but not CCK-4, enhances dopamine turnover in the posterior nucleus accumbens: a microdialysis study in freely moving rats. Brain Res. 657: 1-6.
14. LADURELLE, N., DURIEX, C., ROQUES, B.P. and DAUGÉ, V. (1994) Different modifications of the dopamine metabolism in the core and shell parts of the nucleus accumbens following CCK-A receptor stimulation in the shell region. Neuroscience Letters 178: 5-10.
15. 2 receptors induced by cholecystokinin receptor subtypes in rat neostriatal membranes. Brain Res. 650: 289-298.
16. MANN, P.E.; FELICIO, L.F. and BRIDGES, R.S. (1995) Investigation into the role of cholecystokinin (CCK) in the induction and maintenance of maternal behavior in rats. Horm. and Behav. 29: 392-406.
17. MEEK, J.L., IADAROLA, M.J. and GIORGI, O. (1983) Cholecystokinin turnover in brain. Brain Res. 276:375-378.
18. MORAN, T.H. and MCHUGH, P.R. (1990) Cholecystokinin receptors. In: Handbook of Chemical Neuroanatomy, vol.9: Neuropeptides in the CNS, Part II, A. Björklund, T.Hökfelt and M.J. Kuhar (Eds.), pp 455-476, Elsevier, Amsterdan, NE
19. B receptor antagonist L-365,260. Eur. J. Pharmacol. 193:203-208.
20. PELLEGRINO, L.J., PELLEGRINO, A.S. and CUSHMAN, A.J. (1986) A Stereotaxic Atlas of the Rat Brain, Plenum Press, N.Y.
21. RASMUSSEN, K, HOWBERT, J.J. and STOCKTON, M.E. (1993) Inhibition of A9 and A10 dopamine cells by the cholecystokinin-B antagonist LY262691: mediation through feedback pathways from forebrain sites. Synapse 15: 95-103.
22. SAVASTA, M., PALACIOS, J.M. and MENGOD, G. (1988) Regional localization of the mRNA coding for the neuropeptide cholecystokinin in the rat brain studied by in situ hybridisation. Neuroscience Letters, 93: 132-138.
23. SAVASTA, M., RUBERTE, E., PALACIOS, J.M. and MENGOD, G. (1989) The colocalisation of cholecystokinin and tyrosine hydroxylase mRNAs in mesencephalic dopaminergic neurons in the rat brain examined by in situ hybridisation. Neurosci. 29: 363-369.
24. SNYDER, G.L., FISONE, G., MORINO, P., GUNDERSEN, V., OTTERSEN, O.P., HÖKFELT, T. and GREENGARD, P. (1993) Regulation by the neuropeptide cholecystokinin (CCK-8S) of protein phosphorylation in the neostriatum. Proc. Natl. Acad. Sci. USA. 90: 11277-11281.
25. 3H-dopamine release from superfused rat striatal slices. Neurochem. Int. 4: 63-78.
26. TIEPPO, C.A., SILVA A.M.P., PALERMO-NETO, J., NASELLO, A.G. and FELICIO, L.F. (1995) Intracerebroventricular administration of cholecystokinin reduces stereotypy in dopamine-supersensitive rats. Braz. J. Med. Biol. Res. 28: 351-354.
27. TRONCONE, L.R.P., FERREIRA, T.M.S., BRAZ, S., SILVEIRA-FILHO, N.G. and TUFIK, S. (1988) Reversal of increase in apomorphine-induced stereotypy and agression in REM sleep deprivated rats by dopamine agonists pretreatment. Psychopharmacol. 94: 79-83.
28. VACARINO, F.J. (1994) Nucleus accumbens dopamine-CCK interactions in psychostimulant reward and related behaviors. Neurosci. Biobehav. Rev. 18: 207-214.
29. VAN REE, J.M., GAFFORI, O. and DE WIED, D. (1983) In rats, the behavioral profile of CCK-8 related peptides resembles that of antipsychotic agents. Eur. J. Pharmacol. 93: 63-78.
30. 3H] dopamine efflux from rat nucleus accumbens. Neuropeptides 13: 43-50.
31. WANG, R.Y. (1988) Cholecystokinin, dopamine, and schizophrenia: recent progress and current problems. Ann. NY Acad. Sci. 537: 362-379.
32. WEISS, F. and ETTENBERG, A. (1986) Comparison of circling induced by unilateral intrastriatal microinjections of haloperidol, clozapine and CCK-8 in rats. Pharmacol. Biochem. Behav. 24: 983-989.
33. WEISS, F. and ETTENBERG, A. (1986) Comparison of circling induced by unilateral intrastriatal microinjections of haloperidol, clozapine and CCK-8 in rats. Pharmacol. Biochem. Behav. 24: 983-989.
34. WEISS, F., ETTENBERG, A. and KOOB, G.F. (1989) CCK-8 injected into the nucleus accumbens attenuates the supersensitive locomotor response to apomorphine in 6-OHDA and chronic-neuroleptic treated rats. Psychopharmacol. 99: 409-415.
35. WEISS, F., TANZER, D.J. and ETTENBERG, A. (1988) Opposite actions of CCK-8 on amphetamine-induced hyperlocomotion and stereotypy following intracerebroventricular and intra-accumbens injections in rats. Pharmacol. Biochem. Behav. 30: 309-317.
36. WORMS, P., MARTINEZ, J., BRIET, C., CASTRO, B. and BIZIERE, K. (1986) Evidence for dopaminomimetic effect of intrastriatally injected cholecystokinin octapeptide in mice. Eur. J. Pharmacol. 121: 395-401.
37. YOU, Z.B., HERRERA-MARSCHITZ, M., BRODIN, E., MEANA, J.J., MORINO, P., HÖKFELT, T., SILVEIRA, R., GOINY, M. and UNGERSTEDT, U. (1994) On the origin of striatal cholecystokinin release: studies with in vivo microdialysis. J. Neurochem. 62: 76-85.
38. ZETLER, G. (1985) Antistereotypic effects of cholecystokinin octapeptide (CCK-8), ceruletide and related peptides on apomorphine-induced gnawing in sensitized mice. Neuropharmacol. 24: 251-259.